Comparison of Outcomes Twelve Years After Antireflux Surgery or Omeprazole Maintenance Therapy for Reflux Esophagitis

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 12, 2009, Pages 1292-1298

  Lundell, Lars ^a   Miettinen, Pekka ^b   Myrvold, Helge E ^c   Hatlebakk, Jan G ^d   Wallin, Lene ^e   Engström, Cecilia ^f   Julkunen, Risto ^b   Montgomery, Madeline ^g   Malm, Anders ^h   Lind, Tore ^h   Walan, Anders ^h  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g ERSTA HOSPITAL   (Sweden)

^h ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ADULT; AGED; ANTIREFLUX OPERATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPHAGIA; FEMALE; FLATULENCE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; REMISSION; STOMACH FUNDOPLICATION; TREATMENT OUTCOME;

ADULT; AGED; ENZYME INHIBITORS; EUROPE; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70849121346     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.05.021     Document Type: Article

References (30)

1. Spechler S.J. Epidemiology and natural history of gastroesophageal reflux disease. Digestion 51 (1992) 24-29
2. Wienbeck M., and Barnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 24 (1989) 7-13
3. Glise H., and Wiklund I. Measurement of the impact of heartburn and dyspepsia on quality of life. Aliment Pharmacol Ther 11 (1997) 73-77
4. Okamoto K., Iwakiri R., Mori M., et al. Clinical symptoms in endoscopic reflux esophagitis: evaluation in 8031 adult subjects. Dig Dis Sci 48 (2003) 2237-2241
5. Johnson D.A., and Fennerty M.B. Heartburn underestimates erosive oesophagitis in elderly patients with GERD. Gastroenterology 126 (2004) 660-664
6. Vakil N., and Fennerty M.B. Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease. Aliment Pharmacol Ther 18 (2003) 559-568
7. Carlsson R., Galmiche J.P., Dent J., et al. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long term omeprazole trials. Aliment Pharmacol Ther 11 (1997) 437-482
8. Marks R.D., Richter J., Rizzo J., et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology 106 (1994) 907-915
9. Labenz J., Nocon M., Lind T., et al. Prospective follow-up data from the ProGERD study suggests that GERD is not a categorical disease. Am J Gastroenterol 101 (2006) 2457-2462
10. Lundell L., Miettinen P., Myrvold H., et al. Continued (5-year) follow-up of a randomised clinical study comparing antireflux surgery and omeprazole in gastro-oesophageal reflux disease. J Am Coll Surg 192 (2001) 172-181
11. Kahrilas P.J., and Pandolfino J.E. Hiatus hernia in the esophagus. 4th ed. In: Castell D.O., and Richter J.E. (Eds) (2004), Lippincott Williams & Wilkins, Philadelphia 389-407
12. Lundell L., Miettinen P., Myrvold H.E., et al. Seven-year follow-up of randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surg 94 (2007) 198-203
13. Lundell L., Havu N., Miettinen P., et al., Nordic GERD Study Group. Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial. Aliment Pharmacol Ther 23 (2006) 639-647
14. Skinner D.B., Walther B.C., Riddell R.H., et al. Barrett's esophagus: comparison of benign and malignant cases. Ann Surg 198 (1983) 554-566
15. Dupuy H.J. The Psychological General Well-being (PGWB) Index. In: Wenger N.K., Mattson M.E., and Furberg C.F. (Eds). Assessment of quality of life in clinical trials of cardiovascular therapies (1984), Le Jacq Publishing Inc, Hoboken, NJ 170-183
16. Svedlund J., Sjödin I., and Dotevall G. GSRS: a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33 (1988) 129-134
17. Finkelstein D.M. A proportional hazards model for interval-censored failure time data. Biometrics 42 (1986) 845-854
18. Mahon D., Rhodes M., Decadt B., et al. Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux. Br J Surg 92 (2005) 695-699
19. Spechler S.J., Lee E., Ahnen D., et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 285 (2001) 2331-2338
20. Mehta S., Bennett J., Mahon D., et al. Prospective trial of laparoscopic Nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: seven-year follow-up. J Gastrointest Surg 10 (2006) 1312-1317
21. Peracchia A., Bancewicz J., Bonavina L., et al. Fundoplication is an effective treatment for gastro-oesophageal reflux disease. Gastroenterology International 8 (1995) 1-7
22. Catarci M., Gentleschi P., Papi C., et al. Evidence-based appraisal of antireflux fundoplication. Ann Surg 239 (2004) 325-337
23. Anvari M., Allen C., and Borm A. Laparoscopic Nissen fundoplication is a satisfactory alternative to long-term omeprazole therapy. Br J Surg 82 (1995) 938-942
24. Dominitz J.A., Dire C.A., Billingsley K.G., et al. Complications and antireflux medications use after antireflux surgery. Clin Gastroenterol Hepatol 4 (2006) 299-305
25. Luostarinen M.E.S., and Isolauri J.O. Surgical experience improves the long-term results of Nissen fundoplication. Scand J Gastroenterol 34 (1996) 117-120
26. Lundell L., Attwood S., Ell C., et al. Comparing laparoscopic anti-reflux surgery to esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial. Gut 57 (2008) 1207-1213
27. Oelschlager B.K., Quiroga E., Parra J., et al. Long-term outcomes after laparoscopic antireflux surgery. Am J Gastroenterol 103 (2008) 280-287
28. Vakil N., Shaw M., and Kirby R. Clinical effectiveness of laparoscopic fundoplication in a US community. Am J Med 114 (2003) 1-5
29. Allgood P.C., and Bachmann M. Medical or surgical treatment for chronic gastrooesophageal reflux?. A systematic review of published evidence of effectiveness. Eur J Surg 166 (2000) 713-721
30. Ortiz A., Martinez de Haro L.F., Parrilla P., et al. Conservative treatment versus antireflux surgery in Barrett's esophagus: long-term results of a prospective study. Br J Surg 83 (1996) 274-278